Science Explorer Back to mapMap
Discussion
Researcher · Nilai University · Malaysia

Kananathan Ratnavelu

Kananathan Ratnavelu publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Immunology, on topics such as Lung Cancer Treatments and Mutations, Immune Cell Function and Interaction and Lung Cancer Diagnosis and Treatment.

OpenAlex
World rank
#4,607,230
of 7,710,434 ranked researchers
Rank in Malaysia
#22,305
of 41,196
Works
15
Citations
425
Citations per work
28.3
h-index
9
i10-index 7Top 58% in Pulmonary and Respiratory Medicine
Kananathan Ratnavelu

What does Kananathan Ratnavelu research?

Kananathan Ratnavelu's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (13%).

Health Sciences: 8 works · 51.1% of their workMedicine: 8 works · 51.1% of their workPulmonary and Respiratory Medicine: 4 works · 26.7% of their workOncology: 4 works · 24.4% of their workLife Sciences: 4 works · 28.9% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 15.6% of their workMolecular Biology: 1 works · 8.9% of their workCancer Research: 1 works · 6.7% of their workImmunology and Microbiology: 2 works · 13.3% of their workImmunology: 2 works · 13.3% of their workEverything else: 2 works · 11.1% of their workSocial Sciences: 1 works · 8.9% of their workEconomics, Econometrics and Finance: 1 works · 8.9% of their workEconomics and Econometrics: 1 works · 8.9% of their workTHEIR WORKKananathanRatnavelu15works
Life Sciences29%Health Sciences51%Social Sciences9%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine851.1%
    1. Biochemistry, Genetics and Molecular Biology215.6%
    2. Immunology and Microbiology213.3%
  3. Everything else211.1%
    1. Economics, Econometrics and Finance18.9%
  1. 1Pulmonary and Respiratory Medicine27% of their works
  2. 2Oncology24% of their works
  3. 3Immunology13% of their works
  4. 4Economics and Econometrics9% of their works
  5. 5Molecular Biology9% of their works
  6. 6Cancer Research7% of their works

Research topics

Which keywords describe Kananathan Ratnavelu's research?

The keywords of their largest research topics: Targeted Therapy, ALK Inhibitors, EGFR Mutations, Cancer Immunotherapy, CT Screening, Lung Cancer, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Targeted Therapy82 topics
  2. ALK Inhibitors61 topic
  3. EGFR Mutations61 topic
  4. Cancer Immunotherapy42 topics
  5. CT Screening31 topic
  6. Lung Cancer31 topic
  7. NK Cell Recognition31 topic
  8. Natural Killer Cells31 topic
  9. CAR T Cells21 topic
  10. Cancer Genomics21 topic
  11. Cancer Incidence21 topic
  12. Chimeric Antigen Receptor21 topic
  13. Dendritic Cells21 topic
  14. Immune Checkpoint Blockade21 topic
  15. Immunity21 topic
  16. Mortality Rates21 topic
  17. Mutational Signatures21 topic
  18. PD-1 and PD-L121 topic

Where does Kananathan Ratnavelu work?

Kananathan Ratnavelu's main affiliation in the publication record is Nilai University, Malaysia.

How many publications and citations does Kananathan Ratnavelu have?

OpenAlex counts 15 works and 425 citations for Kananathan Ratnavelu, an h-index of 9, ranking #4,607,230 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kananathan Ratnavelu. Posts are plain text and can be reported.